Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Clinical trial NCT01846793 · COMPLETED

Trial details

NCT number: NCT01846793
Sponsor: Nymox Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia BPH Lower Urinary Tract Symptoms (LUTS)LUTS

Start date: 2013-04-01
Primary completion: 2014-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.